Literature DB >> 16520995

Risk factors for reperfusion injury after lung transplantation.

Silvia R Cottini1, Nicolas Lerch, Marc de Perrot, Miriam M Treggiari, Anastase Spiliopoulos, Laurent Nicod, Bara Ricou.   

Abstract

OBJECTIVE: To assess the influence of recipient's and donor's factors as well as surgical events on the occurrence of reperfusion injury after lung transplantation. DESIGN AND
SETTING: Retrospective study in the surgical intensive care unit (ICU) of a university hospital.
METHODS: We collected data on 60 lung transplantation donor/recipient pairs from June 1993 to May 2001, and compared the demographic, peri- and postoperative variables of patients who experienced reperfusion injury (35%) and those who did not.
RESULTS: The occurrence of high systolic pulmonary pressure immediately after transplantation and/or its persistence during the first 48 h after surgery was associated with reperfusion injury, independently of preoperative values. Reperfusion injury was associated with difficult hemostasis during transplantation (p=0.03). Patients with reperfusion injury were more likely to require the administration of catecholamine during the first 48 h after surgery (p=0.014). The extubation was delayed (p=0.03) and the relative odds of ICU mortality were significantly greater (OR 4.8, 95% CI: 1.06, 21.8) in patients with reperfusion injury. Our analysis confirmed that preexisting pulmonary hypertension increased the incidence of reperfusion injury (p<0.01).
CONCLUSIONS: Difficulties in perioperative hemostasis were associated with reperfusion injury. Occurrence of reperfusion injury was associated with postoperative systolic pulmonary hypertension, longer mechanical ventilation and higher mortality. Whether early recognition and treatment of pulmonary hypertension during transplantation can prevent the occurrence of reperfusion injury needs to be investigated.

Entities:  

Mesh:

Year:  2006        PMID: 16520995     DOI: 10.1007/s00134-006-0096-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  19 in total

Review 1.  Lung transplantation.

Authors:  E P Trulock
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

2.  Does donor cause of death affect the outcome of lung transplantation?

Authors:  Anna Maria Ciccone; Ken C Stewart; Bryan F Meyers; Tracey J Guthrie; Richard J Battafarano; Elbert P Trulock; Joel D Cooper; G Alexander Patterson
Journal:  J Thorac Cardiovasc Surg       Date:  2002-03       Impact factor: 5.209

3.  Antithrombin III prevents early pulmonary dysfunction after lung transplantation in the dog.

Authors:  A Salvatierra; R Guerrero; M Rodriguez; A Alvarez; F Soriano; R Lopez-Pedrera; R Ramirez; J Carracedo; F Lopez-Rubio; J Lopez-Pujol; F Velasco
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

4.  Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation.

Authors:  Marc De Perrot; Yasuo Sekine; Stefan Fischer; Thomas K Waddell; Karen McRae; Mingyao Liu; Dennis A Wigle; Shaf Keshavjee
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

5.  Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation.

Authors:  G Thabut; O Brugière; G Lesèche; J B Stern; K Fradj; P Hervé; G Jebrak; J Marty; M Fournier; H Mal
Journal:  Transplantation       Date:  2001-05-15       Impact factor: 4.939

6.  Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation.

Authors:  R C King; O A Binns; F Rodriguez; R C Kanithanon; T M Daniel; W D Spotnitz; C G Tribble; I L Kron
Journal:  Ann Thorac Surg       Date:  2000-06       Impact factor: 4.330

7.  Outcomes from paired single-lung transplants from the same donor.

Authors:  G I Snell; T Shiraishi; A Griffiths; B Levvey; T Kotsimbos; D S Esmore; T J Williams
Journal:  J Heart Lung Transplant       Date:  2000-11       Impact factor: 10.247

8.  Influence of preservation solution on early graft failure in clinical lung transplantation.

Authors:  G Thabut; I Vinatier; O Brugière; G Lesèche; P Loirat; A Bisson; J Marty; M Fournier; H Mal
Journal:  Am J Respir Crit Care Med       Date:  2001-10-01       Impact factor: 21.405

9.  Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.

Authors:  Y J Gu; J de Haan; U P Brenken; W J de Boer; J Prop; W Van Oeveren
Journal:  J Thorac Cardiovasc Surg       Date:  1996-09       Impact factor: 5.209

10.  Lung transplant edema: chest radiography after lung transplantation--the first 10 days.

Authors:  D C Anderson; H S Glazer; J W Semenkovich; T K Pilgram; E P Trulock; J D Cooper; G A Patterson
Journal:  Radiology       Date:  1995-04       Impact factor: 11.105

View more
  8 in total

Review 1.  Year in Review in Intensive Care Medicine, 2006. III. Circulation, ethics, cancer, outcome, education, nutrition, and pediatric and neonatal critical care.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard
Journal:  Intensive Care Med       Date:  2007-02-14       Impact factor: 17.440

2.  Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model.

Authors:  Damien J LaPar; Victor E Laubach; Abbas Emaminia; Ivan K Crosby; Vanessa A Hajzus; Ashish K Sharma; Heather M Sumner; David V Webb; Christine L Lau; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2011-07-16       Impact factor: 5.209

3.  MMP2 and MMP9 contribute to lung ischemia-reperfusion injury via promoting pyroptosis in mice.

Authors:  Peng Zhou; Nai-Cheng Song; Zhi-Kun Zheng; Yi-Qing Li; Jin-Song Li
Journal:  BMC Pulm Med       Date:  2022-06-15       Impact factor: 3.320

4.  Priming donor lungs with thioredoxin-1 attenuates acute allograft injury in a rat model of lung transplantation.

Authors:  Hanbo Hu; Li Lu; Wei Mu; Richard J Johnson; Edward R Block; Jawaharlal M Patel
Journal:  J Heart Lung Transplant       Date:  2008-08-27       Impact factor: 10.247

5.  NOX2 is involved in CB2-mediated protection against lung ischemia-reperfusion injury in mice.

Authors:  Wei Huang; Yaqin Xiong; Yali Chen; Yan Cheng; Rurong Wang
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

Review 6.  Treatment of pulmonary hypertension.

Authors:  Rajendrakumar Patel; Wilbert S Aronow; Laxeshkumar Patel; Kaushang Gandhi; Harit Desai; Dhiraj Kaul; Sumir P Sahgal
Journal:  Med Sci Monit       Date:  2012-04

7.  Resolvin D1 mitigates energy metabolism disorder after ischemia-reperfusion of the rat lung.

Authors:  Qifeng Zhao; Ji Wu; Qingwang Hua; Zhiyong Lin; Leping Ye; Weixi Zhang; Guowei Wu; Jie Du; Jie Xia; Maoping Chu; Xingti Hu
Journal:  J Transl Med       Date:  2016-03-24       Impact factor: 5.531

8.  Lipoxin A4 attenuates the lung ischaemia reperfusion injury in rats after lung transplantation.

Authors:  Lijuan Zhang; Qihang Tai; Guangxiao Xu; Wei Gao
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.